We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bayshore

News List

Bayshore Voluntarily Recalls Extended Release Metformin americanpharmaceuticalreview
August 25, 2020
The U.S. Food and Drug Administration (FDA) is alerting patients and health care professionals to Bayshore Pharmaceuticals’ voluntary recall of two lots of extended release (ER) metformin (one lot of 750 mg tablets and one lot of 500 mg tablets).
Bayshore Issues Voluntary Nationwide Recall of Metformin Hydrochloride americanpharmaceuticalreview
August 24, 2020
Bayshore Pharmaceuticals is voluntarily recalling one (1) lot of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg, 1000 count bottles and one (1) lot of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 count bottles within ...